German-made, multi-dose preservative-free artificial tears containing high molecular weight sodium hyaluronate provide moisturizing lubrication and promote corneal epithelial repair. They offer superior ocular surface comfort, relieve dry eye symptoms, and enhance corneal healing. Since its introduction in 1999, this product has obtained pharmaceutical registrations in multiple countries and is now sold in over 70 countries worldwide.

Micro-needle eye mask, applying the "transdermal drug delivery technology” originated from a key invention of a Japanese medical laboratory, enabling users to have medical-level care at home. Medical evidence shows safe and effective release of worries about trauma, pain, escharotic and reconstruction. With simple ingredients, high efficacy and 40+ patents, it effectively relieves the symptoms of dark circles, fine lines around the eyes, etc.

A leading brand of medical skin care originated from Sato Pharm, Japan, with unique basal repair components, DDS drug extended-released osmosis technology, Sato Pharm’s exclusive ointment technology, plant essence extraction and mixing technology. Excellula enables in-depth skin care, exploring the potential of skin cells, stimulating healthy beauty from inner skin.

BAHEAL® Heartpal Home ECG is a 12-lead home ECG device meeting medical-grade ECG standards. It offers diagnostic support equivalent to hospital-grade equipment and is suitable for out-of-hospital ECG monitoring for cardiovascular disease patients and high-risk individuals. Unlike single-lead or three-lead devices, BAHEAL® Heartpal Home ECG not only detects arrhythmias but also promptly monitors myocardial ischemia and myocardial infarction, buying critical treatment time for heart attack patients, and is characterized for its lightweight design, easily operability even by non-professionals at any time and place. Currently, BAHEAL® Heartpal Home ECG holds a national invention patent and has obtained Class II medical device certification in China,

GlowingPro, as Baheal's newly launched children's nutrition brand, presents this liquid lutein supplement—sugar-free and gelatin-free. Its scientifically formulated, highly absorbable formula provides comprehensive eye health protection. Formulated based on the clinically validated AREDS2 formula from the U.S. National Institutes of Health, it incorporates eye-protective ingredients like bilberry extract, vitamin E, and zinc. It is also specially recommended by the nutrition team at UCLA Medical School. Its triple-layer microcapsule technology (patented Actilease®) ensures stable release of active ingredients, enhancing absorption and increasing bioavailability by 126%.

Bi Bai Ke originates from the Qing Dynasty imperial prescription “Wan Ying Ding,” a formula for clearing heat and detoxifying the body. It uses natural bear bile powder as its primary ingredient, with each tablet containing 11.1mg of bear bile powder. It is formulated with authentic herbs such as wine-processed rhubarb and Coptis chinensis, following a rigorous and well-balanced formulation. It is specifically used for various symptoms of “heat” in the body, offering unique therapeutic effects.

CSL Behring is one of the largest import suppliers in China's human albumin market. Baheal has collaborated with CSL Behring since 2018 and remains a key partner for CSL Behring in China. Human albumin is a life-saving product primarily used to treat shock caused by hemorrhagic trauma or burns, as well as for the prevention and treatment of hypoalbuminemia. Due to factors such as stringent market regulation, increased clinical demand, and limited plasma supply, China's human albumin market has consistently faced a supply shortage.

Utidelone Injection is a tumor chemotherapy drug and a Class I innovative drug developed by Huahai Zhongtian (China's first publicly listed synthetic biology pharmaceutical company). (First approved indication) It is indicated for the treatment of recurrent or metastatic advanced breast cancer. Compared to taxane drugs, it offers superior safety, enhanced efficacy, reduced susceptibility to drug resistance, and the ability to cross the blood-brain barrier.

JI LUN TAI is committed to providing comprehensive solutions for nuclear medicine molecular imaging diagnosis and treatment. We focus on the research and development of top-level radioactive drugs with independent intellectual property rights in global scale, driving equipment innovation along with drug innovation. Our pipeline covers multiple fields including SPECT diagnostic medicines, PET diagnostic medicines, targeted therapeutic drugs and imaging equipment.

ZAP Surgical specializes in precision brain radiotherapy and has pioneered a dedicated robotic radiosurgery system for intracranial and head & neck tumors and lesions. Its innovative technology delivers precise, efficient, and safe stereotactic radiosurgery to patients worldwide. The system has obtained market approval in 24 countries and regions and has completed over 5,000 clinical treatments.

BRIOHEALTH SOLUTIONS focuses on the research and development of the global state-of-the-art ventricular assist device (VAD). The company has developed a new generation of  BrioVAD® with totally magnetic levitation technology, which has been launched in 2022. Implantation operations has undergone in more than 70 of China's top cardiovascular hospitals. The product has commenced clinical trials in the United States and is covered by American medical insurance. It is the first implantable medical device from China to obtain clinical approval in the United States.

Baheal Wisart focuses on cutting-edge technologies transformation and innovative medicines R&D of the cardiovascular diseases. It possesses internationally leading technologies for the preservation, isolation, cultivation and cryopreservation of human primary cardiomyocytes. Based on State Key Laboratory of Cardiovascular Disease, Baheal Wisart is fully committed to the R&D and translation of cardiovascular diseases innovative medicines, effectively serving the national strategic needs for the prevention and treatment of cardiovascular diseases.

Based on State Key Laboratory of Cardiovascular Disease, Baheal Guoxin is committed to the R&D of breakthrough technologies and achievement transformation platform for Cardiovascular Medical Devices. With the non-invasive radiotherapy system for arrhythmia as its core breakthrough, the enterprise innovatively integrates radiotherapy with cardiac electrophysiology to transform its treatment methods from invasive surgery to precise and non-invasive therapies, to drive a technological revolution in cardiovascular diseases treatment.